A complete application in a minute
Tailored resume and cover letter, ready to send.
Scorpion Therapeutics seeks a Cardiometabolic Medical Science Liaison (MSL) to join our Medical Affairs team. The role focuses on supporting RNAi-based therapeutics for hypertriglyceridemia and familial chylomicronemia syndrome through robust scientific engagement with cardiologists and endocrinologists.
You will educate on RNAi indications, collaborate with internal teams, support clinical trial sites, and represent the therapeutic area at congresses while traveling within a defined territory.
Within Medical Affairs, focusing on supporting clinical stage and launch activities for RNAi-based therapeutics targeting hypertriglyceridemia and familial chylomicronemia syndrome.
Responsibilities include engaging healthcare professionals (cardiologists, endocrinologists) through scientific exchanges, educating on RNAi technology and indications, supporting clinical trial sites, and disseminating scientific insights. The role involves attending scientific congresses, monitoring literature and competitive landscape, developing educational content, and collaborating with internal teams through sophisticated stakeholder management.
PhD, PharmD, MD, or DO; 5+ years as an MSL with cardiometabolic experience; strong communication, scientific interpretation, and project management skills; industry experience in biotech or pharma medical affairs; ability to travel.
cardiometabolic (hypertriglyceridemia, familial chylomicronemia, hypercholesterolemia), therapeutic area expertise, support for clinical trials, stakeholder engagement in real-world settings, and scientific education.
field-based position within a specified territory; travel required.